tykhr
sign in
free sign up
NovaBay Pharmaceuticals Inc
Biotechnology
Healthcare
NBY
5.82 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
2.08
52 week high
4.22
high
2.15
52 week low
0.00
low
2.03
growth
20.22 %
previous Close
2.11
P/E ratio
market cap
9.61 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-1.92 M
-125.06 %
eps
0.00 %
-25.55 %
eps surprise
-3500.00 %
net profit margin
-192200000.00 %
-332.00 %
operating incoming
-1.89 M
42.52 %
net change in cash
-3.12 M
-138.86 %
cash on hand
5.34 M
-36.88 %
cost of revenue
38.00 K
-30.91 %
top